CD19 and systemic lupus erythematosus: NCT03030976 is based on classical anti-CD19 CAR-Ts to deplete B cells in CD19+ systemic lupus erythematosus (SLE), in which the immune system attacks its own tissues, causing widespread inflammation and tissue damage in the affected organs.